abstract |
The present invention relates to a peptide compound His-Ser-Leu-Gly as a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. -Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe. In addition, the invention optionally comprises a peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-, in combination with at least one pharmaceutically acceptable carrier, antifreeze, lyophilizer, excipient and / or diluent. It relates to a pharmaceutical composition containing Pro-Asp-Lys-Phe, preferably in the form of a lyophilizate or liquid buffer or artificial breast milk preparation or breast milk substitute. |